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Background: Infection of burn wounds by multidrug-resistant (MDR) Pseudomonas aeruginosa  (P. 
aeruginosa) is a leading cause of morbidity and mortality and remains one of the most challenging concerns for 
the burns unit. The aim of this study is purify and characterize the haemolysin produced by multidrug resistant 
P. aeruginosa PAO1 isolated from burn wounds.                                    
Methods: Isolation and identification of P. aeruginosa from burns was done by standard bacteriological 
methods. P. aeruginosa PAO1 was identified by PCR amplification and sequencing of the 16S rRNA gene. The 
haemolysin of P. aeruginosa PAO1 was purified by 70% ammonium sulphate precipitation followed by gel 
filtration on Sephadex G-100, and separation by SDS-Poly Acrylamide Gel Electrophoresis. In vivo toxicity of 
the purified haemolysin was determined by intraperitoneal injection of Swiss albino mice, and in vitro toxin-
antitoxin neutralization test was performed as previously described.                      
Results: The pure haemolysin had a molecular weight of 37 kDa, with maximum activity at 25°C for 30 
minutes and stable within pH range of 4-9 (maximum activity at pH 7). The haemolysin was activated by Ca2+, 
Fe3+ and Cu2+. Intraperitoneal injection of mice with 0.5ml of haemolysin (128 HU/ml) caused 100% mortality 
while 0.5 and 0.1 ml of haemolytic titer (64 HU/ml) of the heated haemolysin (toxoid) caused 50% and 0% 
mortality respectively. In vitro toxin-antitoxin neutralization test revealed that anti-haemolysin antitoxin was 
present in the serum of the mice that were previously vaccinated with heated toxin.                    
Conclusion: This study concluded that haemolysin can be a potential vaccine component for prevention of 
haemolysis caused by multidrug resistant P. aeruginosa in burn patients. 
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Abstrait:                                                                                                             
 
Contexte: L'infection des plaies par brûlures par Pseudomonas aeruginosa (P. aeruginosa) multirésistante 
(MDR) est l'une des principales causes de morbidité et de mortalité et demeure l'une des préoccupations les  
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plus difficiles pour l'unité des brûlures. Le but de cette étude est de purifier et de caractériser l'hémolysine 
produite par P. aeruginosa PAO1 multirésistante isolée de brûlures.                                                                                                                                                                                                                                                                                                                                                                                                                     
Méthodes: L'isolement et l'identification de P. aeruginosa des brûlures ont été effectués par des méthodes 
bactériologiques standard. P. aeruginosa PAO1 a été identifié par amplification par PCR et séquençage du gène 
d'ARNr 16S. L'hémolysine de P. aeruginosa PAO1 a été purifiée par une précipitation au sulfate d'ammonium à 
70% suivie d'une filtration sur gel sur Sephadex G-100 et d'une séparation sur électrophorèse par gel SDS-Poly 
Acrylamide. La toxicité in vivo de l'hémolysine purifiée a été déterminée par injection intrapéritonéale de souris 
albinos suisses et un test de neutralisation in vitro toxine-antitoxine a été effectué comme décrit 
précédemment.                                 
Résultats: L'hémolysine pure avait un poids moléculaire de 37 kDa, avec une activité maximale à 25°C 
pendant 30 minutes et stable dans une plage de pH de 4 à 9 (activité maximale à pH 7). L'hémolysine a été 
activée par Ca2+, Fe3+ et Cu2+. L'injection intrapéritonéale de souris avec 0,5 ml d'hémolysine (128 HU/ml) a 
causé une mortalité de 100% tandis que 0,5 et 0,1 ml de titre hémolytique (64 HU/ml) de l'hémolysine 
chauffée (anatoxine) ont causé respectivement 50% et 0% de mortalité. Un test de neutralisation in vitro 
toxine-antitoxine a révélé que l'antitoxine anti-hémolysine était présente dans le sérum des souris 
préalablement vaccinées avec de la toxine chauffée.                      Conclusion: Cette étude a conclu que l'hémolysine peut être un composant vaccinal potentiel pour la prévention de l'hémolyse causée par P. aeruginMots-clés: hémolysine, Pseudomonas aeruginosa,  
Conclusion: Cette étude a conclu que l'hémolysine peut être un composant vaccinal potentiel pour la 
prévention de l'hémolyse causée par P. aeruginosa multirésistante chez les patients brûlés.  
Mots-clés: hémolysine, Pseudomonas aeruginosa, organisme multirésistant 
Introduction: 
 Infection in burn patients is a leading 
cause of morbidity and mortality and remains 
one of the most challenging concerns for the 
burns  unit (1). Multidrug-resistant (MDR) 
Pseudomonas aeruginosa  (P. aeruginosa) is 
an emerging cause of mortality and morbidity 
in burn patients, which is estimated to cause 
4-60% of nosocomial infections in different 
parts of the world (2).   
 Numerous P. aeruginosa virulence 
factors contribute to the pathogenesis of 
wound infections in patients with burns. Pili 
and flagella are essential for the organism 
ability to persist in burns wound and cause 
disseminated infections (3). P. aeruginosa 
elaborate many toxic products and enzymes 
such as catalase, lipase, lecithinase, elastase, 
proteases and haemolysins, which enable the 
organism to invade and destroy the host 
tissues (4-6). In particular, haemolysin cont- 
ributes to virulence of P. aeruginosa, and 
decreased haemolytic activity has been 
associated with decrease virulence (7). 
 The aim of current study is to purify 
and characterize the haemolysin produced by 
MDR P. aeruginosa PAO1 isolated from burn 
patients as a preliminary step to producing 
toxoid from it.  
Materials and method: 
Study setting    
 This study was conducted in the 
Medical Microbiology and Immunology 
Department, Faculty of Medicine, and Botany 
Department Faculty of Science, Zagazig 
University, Egypt. Approval for performing 
the study was obtained from Institutional 
Review Board of Faculty of Medicine, Zagazig 
University. Consent was obtained from each 
patient enrolled in the study. All experiments 
were carried out in compliance with the 
relevant laws and guidelines. 
Collection of specimens   
 Forty five swab specimens were 
collected using sterile cotton swabs from 
patients with burn wound infections in 
Central Hehia Hospital, Hehia city, El-Sharkia, 
Egypt during the period July to September 
2013. All samples were transported to the 
Medical Microbiology and Immunology 
Department, Faculty of Medicine, Zagazig 
University, within two hours of collection.  
Isolation and identification of Pseudomonas 
aeruginosa 
 The swabs were cultured on nutrient, 
MacConkey and blood agar plates, and 
incubated aerobically at 37oC for 24 hours. 
Colonies were identified as P. aeruginosa on 
culture plates using standard bacteriological 
methods (8). Antibiotic susceptibility of P. 
aeruginosa isolates was determined by the 
CLSI disk diffusion method (9). The identity 
of the MDR P. aeruginosa was confirmed by 
PCR amplification and sequencing of the 16S 
rRNA gene at the Sequence Unit, Sigma 
Company, Giza, Egypt as P. aeruginosa PAO1 
(NR 074828 1). 
Determination of haemolysin level 
  The haemolysin level of P. aeruginosa 
PAO1 (NR 074828 1) was determined by the 
modified disk diffusion method (10). The 
overnight broth culture of the isolates was 
diluted in sterile saline to 0.5 McFarland 
standards. Sterile filter paper disk was imm- 
ersed in each bacterial suspension to absorb 
0.01ml. The disks were placed on the surface 
of blood agar medium and incubated over- 
night at 37°C. Diameters of haemolysis (H) 
and growth (G) zones were measured and 
the H/G ratio was determined.                
Haemolysin purification   
 P. aeruginosa PAO1 (NR 074828 1) was 
grown in nutrient broth medium at optimum 
conditions for maximum haemolysin produc- 
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tion. The medium was optimized in presence 
of glucose as carbon source and yeast 
extract as nitrogen source at pH 7.0 for 2 
days. The culture supernatant was mixed 
with 70% ammonium sulphate concentration, 
with constant stirring at 4°C overnight. The 
precipitate was then separated by centri- 
fugation at 4000 rpm for 20 minutes and re-
suspended in small amount of phosphate 
buffer (pH 7.0). The re-suspended pellets 
were applied to a Sephdex G-100 column 
pre-equilibrated with the same buffer. The 
active fractions were collected, pooled and 
concentrated by dialysis against the same 
buffer. For each fraction, protein content and 
haemolytic activity were determined by 
methods previously described (11,12).   
Haemolytic titer   
 The titer of P. aeruginosa PAO1 hae- 
molysin was determined using two fold 
dilution method (13). 0.5ml of haemolysin of 
was diluted by two fold serial dilutions in 
0.5ml phosphate buffered saline (pH 7.4). 
0.5ml of 1% suspension of red cells was 
added to tubes containing the dilutions of the 
haemolysin. The final readings were made 
visually after 2hours of incubation at 37°C in 
a water bath. The reciprocal of the highest 
dilution showing complete haemolysis was 
taken as the number of haemolytic units per 
ml (HU/ml) present in the preparations 
Determination of molecular weight  
 SDS-polyacrylamide gel electropho- 
resis (SDS-PAGE) was carried out to deter- 
mine the purity and molecular weight of the 
protein, as described by Laemmli (14) using 
12% separating acrylamide gel. 
Amino acid analysis  
 Amino acid composition of the 
purified protein was determined by applying 
the GLC hydrolytic technique (15) with a 
Beckman amino acid analyzer system 
(Sykam-S 7130 Amino Acids, Reagent Orga- 
izer).   
 
Biochemical properties of purified haemolysin
 Thermal stability of the haemolysin 
was studied after pre-incubation at various 
temperature (25, 37, 45, 55 and75°C) using 
0.01M phosphate buffer (pH 7.0) for different 
periods of time (30, 60, 90 and 120 
minutes).  A 1% RBCs suspension was added 
to the haemolysin (0.5 ml/0.5 ml v/v). The 
thermal inactivation rate (Kr min) was 
described by the first-order kinetic model 
(16); Ln (At/A0) ktT, where Ao and At are the 
specific activity at zero and ‘t’ time 
respectively. The T1/2 (time at which the 
haemolysin loses 50% of its activity) was 
calculated from the linear equation for each 
temperature. The temperature at which the 
haemolysin loses 50% of its activity (Tm) 
was calculated from the linear equation of 
different pre-incubation temperature at 60 
minutes.                                                  
 The stability of the haemolysin was 
examined after pre-incubation for 30 minutes 
at different pH values (4, 5, 6, 7, 8 and 9). 
Acetate (0.2M), phosphate (0.2M) and Tris 
HCl (0.2M) buffers were used to create pH 
range 4-5, 6-7 and 8-9 respectively. After 
adding 1% RBCs suspension and incubating 
at 37°C for 2 hours, the haemolytic activity 
was determined for each pH  
 To assay the metal ions effect, the 
purified haemolysin was pre-incubated in 
1mM EDTA at 37°C for 10 minutes and then 
dialyzed against 0.01M phosphate buffer (pH 
7.0). The haemolysin was incubated with 
each metal ion separately for 30 minutes 
before adding 1% RBCs suspension. Metal 
ions in form of FeSO4, CuSO4, MgSO4, 
ZnSO4, CaCO3, Iodine (5mM) as well as EDTA 
(1 and 5mM) were used. The haemolytic 
activity was determined after incubation at 
37°C for 2 hours. 
 
Mice toxicity of fresh and heated haemolysin 
 The purified haemolysin was heated 
for 15minutes in a boiling water bath to 
prepare the toxoid (17). The haemolytic titer 
of the fresh (toxin) and heated (toxoid) 
haemolysin was determined as described 
previously (13). Six groups of four male 
Swiss albino mice (6-8 weeks old) were 
injected intra-peritoneally with doses of 0.5, 
0.3 and 0.1ml of the purified toxin (groups A, 
B and C) and toxoid (groups D, E and F). The 
toxicity reflected by the mortality rate in 




Number of animals that died 
Total number of animals per group
 
            
In vitro toxin-anti-toxin neutralization test 
 Toxin neutralization test was perfor- 
med to detect the presence of serum 
antibodies that can neutralize the haemolytic 
properties of the haemolysin. Blood sample 
was obtained from five Swiss albino mice 
previously immunized by repeatedly injecting 
them with 0.1ml toxoid after which their sera 
were separated. Fifty, 45, 40, 35 and 30µL of 
serum from the immunized mice were added 
to 0, 5, 10, 15 and 20µL of haemolysin 
respectively. 25µL of 1% RBC suspension 
was added to each tube and incubated at 
37°C for 6 hours. All tubes were centrifuged 
for 2 minutes and the supernatants were 
examined for haemolysis. The last tube with 
no haemolysis was the endpoint of the test 
(19), which contains the least concentration 
of the antibody that neutralizes the 
haemolysin. 




Purification of haemolysin  
 As shown in Table 1, the haemolytic 
activity was 32, 64 and 128 HU/ml for the 
crude broth culture filtrate, after precipitation 
with 70% ammonium sulphate and following 
gel filtration chromatography on Sephadex 
G-100 respectively. Compared to the crude 
culture broth filtrate, the haemolysin was 
more purified with purification factor of 29.7 
and 10.7 fold using chromatography and 
70% ammonium sulphate precipitation resp- 
ectively.  The haemolysin was purified as an 
extracellular enzyme from the liquid cultures 
of P. aeruginosa PAO1 growing in broth 
medium (pH7). The purification profile of 
tested haemolysin using sephadex-G100 
showed a sharp peak containing the active 
haemolysin in fractions 9 to 11 with specific 
activity 196.9 Umg-1 proteins compared to 
6.6 Umg-1 of the crude protein (Table 1).   
Molecular weight of purified haemolysin
 Fig 1 shows the SDS-PAGE of the 
purified haemolysin of P. aeruginosa with one 
major band of approximately 37 KDa.  
Amino acids of purified haemolysin             
 As shown in Table 2, the haemolysin 
was composed of 40.2% neutral amino acids 
(glycine, valine, leucine, isoleucine and 
alanine), 20.7% acidic amino acids (glutamic 
acid and aspartic acid), 19.7% basic amino 
acids (lysine and arginine), and 60.9% oxy 
amino acids (serine, threonine and proline). 
The haemolysin has high concentration of   
glycine (26.7%) among other detected amino 
acids.  
Table 1: Purification of the haemolysin from Pseudomonas aeruginosa PAO1 using different methods 














32 4.83 6.62 1.0 100 
70% ammonium 
sulphate 
64 1.12 70.90 10.7 20.9 
Sephadex G-100 128 0.65 196.92 29.7 15.6 
HU = haemolytic units 
 
Table 2: Amino acids composition of P. aeruginosa PAO1 haemolysin 
Amino acid name Concentration 
(mg/100ml) 
Ratio (%) 
Aspartic 2.32 5.76 
Threonine 1.21 3.00 
Serine 1.31 3.25 
Glutamic 6.00 14.92 
Proline 5.42 13.47 
Glycine 10.74 26.7 
Alanine 1.48 3.68 
Valine 1.30 3.23 
Isoleucine 0.94 2.33 
Leucine 1.72 4.27 
Histidine 2.54 6.31 
Lysine 2.81 6.98 
Arginine 2.42 6.01 
 
 
     Fig.1: SDS-PAGE profile of purified      
           haemolysin of Pseudomonas aeruginosa     
           PAO1 shows that molecular weight of the     
           purified enzyme was 37 KDa (Lane 1)      
           when compared to the protein markers      
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Table 3: Biochemical characters of Pseudomonas aeruginosa haemolysin 
 
Temperature (°C) Time (minute) Hemolytic activity 
(HU/ml) 
Relative activity % 
 
25 
30 127.4 100 
60 120.9 94.8 
90 115.6 90.7 




30 107.4 84.3 
60 104.9 82.3 
90 95.4 74.8 




30 87.3 68.5 
60 85.8 67.3 
90 84.7 66.4 




30 75.9 59.6 
60 68.1 53.4 
90 64.0 50.2 




30 55.3 43.4 
60 53.7 42.1 
90 52.8 41.4 
120 48.9 38.4 
Temperature (°C) T½ (min)* Kr minˉ¹** Tm*** (°C) 
25 196.96 0.162 61 
37 230.78 0.145 
45 129.41 0.305 
55 109.79 0.379 
70 85.06 0.499 
Effect of pH on haemolysin activity Effect of ions on haemolysin activity 
pH values Hemolytic activity 
(HU/ml) 
Metal ion (mM) Hemolytic activity 
(HU/ml) 
4 112.8 ± 0.1 Fe3+  (5 mM) 126.1 ± 0.2 
5 114.5 ± 0.4 Cu2+ (5 mm) 120.7 ± 0.7 
6 116.8 ± 0.1 Ca2+ (5 mm) 135.1 ± 0.2 
7 126.7 ± 0.2 Mg2+ (5 mM) 82.5 ± 0.6 
8 115.6 ± 0.4 Zn2+ (5 mM) 74.0 ± 0.3 
9 100.3 ± 0.7 Iodine (5 mM) 59.9 ± 1.0 
  EDTA (5 mM) 61.3 ± 0.3 
  EDTA (1 mM) 104.8 ± 0.8 
  *Half-life times; **Thermal inactivation rate; *** Half-life temperature  
 





Dose (ml) Mortality of mice after days 





0.5 0/4 0 1/4 25 2/4 50 3/4 75 4/4 100 
0.3 0/4 0 0/4 0 0/4 0 0/4 0 ¾ 75 





0.5 0/4 0 0/4 0 0/4 0 0/4 0 2/4 50 
0.3 0/4 0 0/4 0 0/4 0 0/4 0 ¼ 25 
0.1 0/4 0 0/4 0 0/4 0 0/4 0 0/4 0 
HU = haemolytic units 
 
Biochemical properties of purified haemolysin            
 As shown in Table 3, maximum 
activity of the haemolysin was at 25C for 30 
minutes and decline of activity with increased 
exposure time. Also increasing temperature 
decreased enzymatic activity. With regards to 
the thermal kinetic parameters of the 
haemolysin, the half-life (T1/2) was longest 
(230.78 min) at 37°C and half-life temp- 
erature (Tm) was estimated to be 61C. The 
haemolysin was approximately stable within 
pH range of 4-9 and maximum activity was 
at pH 7.0. The activity of the haemolysin was 
increased by the divalent ions Ca2+ followed 
by Fe2+, Cu2+ and 1mM EDTA in that order. 
The haemolysin was inhibited in the presence 
iodine followed by 5mM EDTA, Mg2+ and Zn2 
in that order.                                                                      
Mice toxicity of fresh and heated haemolysin
 As shown in Table 4, intraperitoneal 
(IP) injection of 0.5, 0.3 and 0.1 ml of fresh 
toxin (128 HU/ml) caused mortality rate of 
100%, 75%, and 50% respectively in the 
injected mice. The haemolysin lost its toxicity 
after heating for 15 minutes in boiling water. 
The unprotected mice survived intra- 
peritoneal (IP) injection of 0.1 ml heated 
haemolysin. The haemolysin partially lost its 
toxicity at a dose of 0.5 and 0.3 ml, causing 
mortality rate of 50% and 25% respectively 
in the mice. With respect to the invitro toxin-
antitoxin neutralization test shown in Table 
5, three samples (1, 2, 3) showed no haem- 
olysis with different endpoints while the last 
2 samples (4, 5) showed haemolysis.  
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Table 5: In vitro toxin-anti-toxin neutralization test 
Sample Haemolysis Endpoint 
1 -ve 35 µl 
2 -ve 40 µl 
3 -ve 35 µl 
4 +ve -- 
5 +ve -- 
 
 
Discussion:                                    
Infection by multidrug resistant P. 
aeruginosa is a big challenge in patients with 
burn wounds with tendency to development 
of septicaemia and high risk of death. The 
organism is naturally resistant to a significant 
number of antimicrobials, and infections 
caused by it is therefore associated with high 
mortality rate because  treatment is difficult 
due to reduced availability of effective 
antimicrobials (20). Research into novel the- 
rapies aside conventional antimicrobials is 
recommended to combat these multi-drug 
and sometimes pan-drug resistant organisms 
(21).     
 The anti-virulence approach is one of 
the new strategies to disarm P. aeruginosa 
infective arsenals by inhibiting the expression 
and activity of its virulence factors. This has 
the tendency to reduce its invasiveness and 
avoid emergence of resistance since prolife- 
ration is not affected (22). Haemolysin is one 
of the virulence factors of many organisms. 
P. aeruginosa produces haemolysin to sense 
and sequester iron from its environment, 
which also helps in survival of the pathogen 
by inhibiting host factors (23). Alpha-haemo- 
lysin of uropathogenic Escherichia coli can 
induce apoptosis of target host cells including 
neutrophils, T-lymphocytes and renal cells, 
which promotes exfoliation of epithelial cells 
of the bladder, contributing to nephropatho- 
genicity (24).    
 Cultures of P. aeruginosa considered 
to be of proven virulence have been reported 
to have higher titers of extracellular haemo- 
lysin than cultures of less virulence ones. 
Intra-corneal injection of purified haemolysin 
produced extensive corneal opacification with 
extensive leukocytic infiltration of the tissue 
(25), and it was suggested that P. aeruginosa 
haemolysin played a role in the pathogenesis 
by effecting lysis of host cells and/or sub- 
cellular organelles, leading to the release of 
enzymes destructive to corneal tissue (25). 
Therefore targeting the haemolysin of P. 
aeruginosa can be a new non-antibiotic 
approach in the therapy of MDR strains of 
this organism in burn patients.  
 In this study, we purified, and 
chemically and immunologically characterized 
haemolysin of MDR P. aeruginosa PAO1 as a 
preliminary step to producing a vaccine for 
combating the effect of this virulence factor 
in burn patients. The haemolysin was more 
purified following chromatography with a 
factor of 29.7 fold. The purification profile 
using sephadex-G100 shows a sharp peak 
containing the active haemolysin in fractions 
9 to 11 with specific activity 196.9 U mg-1 
proteins compared to 6.6 U mg-1 of the crude 
protein. Our result agrees with another study 
on P. florescens (26) which reported that 
high performance liquid chromatography 
(HPLC) gives 32.6 fold increases in haemo- 
lysin purification. HPLC increased the purity 
of haemolysin of Bacillus mycoides by 40.8 
folds with the assumption that filtration step 
is the key to the homogeneity observed. 
HPLC increases the purity of haemolysin 
because it polymerizes with other impurities 
(27).      
 Our study showed that using SDS-
PAGE, purified haemolysin of P. aeruginosa 
had one major band with molecular weight of 
approximately 37 kDa. Amino acid analysis of 
the haemolysin also showed that it is a 
hetero polymer. One study estimated the 
molecular weight of haemolysin produced by 
P. aeruginosa to be 78 kDa using both SDS-
PAGE and Sephacryal S-200 column chroma- 
tography while another one estimated it to 
be 76 kDa with high-performance size exclu- 
sion chromatography (28). The molecular 
weight of haemolysins of other organisms 
reported includes 12 kDa for Actinobacillus 
actinomycetemcomitans (29) and 45 kDa for 
Porphyromonas gingivalis (30). Similarly, 
extracellular protein showing haemolysin with 
SDS-PAGE profile of approximately 50 kDa 
was characterized from a pathogenic 
Aeromonas hydrophila strain An4 isolated 
from marine catfish (31).   
 The amino acid composition of the 
haemolysin makes it a good immunogen 
(33), which can induce antibody formation. 
We investigated whether this haemolysin can 
be converted to toxoid by heating it for 15 
minutes in boiling water to prepare the 
toxoid (17). The lack of haemolysis in some 
tubes in the in vitro toxin-antitoxin neutra- 
lization test can be attributed to presence of 
antitoxin in the serum obtained from a 
previously immunized (injected with heated 
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toxin) mice. This serum is believed to contain 
antitoxin which neutralized the haemolysin. 
The samples that showed haemolysis may be 
due to the fact that the titer of the antitoxin 
was too low to neutralize the toxin 
(haemolysin). Other toxins of P. aeruginosa 
have been found to be immunogenic and 
mounted protective immune response in 
mice. Passive immunization of mice with 
antitoxin A gamma globulin protected mice 
against the lethality of intraperitoneal 
infection with P. aeruginosa (34). Pavlovskis 
et al., (35) and Snell et al., (36) observed 
that passive immunization of mice with 
specific antitoxin increased the survival of 
burned mice infected with toxigenic strains 
(but not with non-toxigenic strains) 
compared to control mice. Combining 
antibiotic therapy (gentamicin) with passive 
antitoxin therapy significantly improved the 
survival of the burned infected mice 
compared to infected mice receiving only 
antitoxin (37). 
Conclusion: 
This study concluded that haemo- 
lysin of P. aeruginosa PAO1 is a protein of 
37kDa with 27.7% glycine content. The 
crude haemolysin has a haemolytic activity of 
32 HU/ml and 128 HU/ml after purification 
with gel filtration on Sephadex G-100, with 
maximum activity at 25oC for 30 minutes at 
pH7 with half life temperature (T1/2) of 61
oC. 
The haemolysin activity is enhanced by Ca2+ 
and Fe3+ and inhibited by iodine and 5mM 
EDTA. The haemolysin lost its activity by 
heating for 15 minutes in boiling water and 
induces neutralizing antibodies in vaccinated 
mice. It is recommended that haemolysin of 
P. aeruginosa PAO1 be investigated further 
as a potential component of vaccine for 
prevention of haemolysis caused by multi- 
drug resistant strains of P. aeruginosa in 
burn patients. 
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